Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

First Results from a Nationwide Prospective Non-Interventional Study of Venetoclax-Based 1 st Line Therapies in Patients with Acute Myeloid Leukemia (AML) - Revive Study

Ofir Wolach, MD, Itai Levi, MD, Jonathan Canaani, MD, Tamar Tadmor, MD, Sigal Tavor, MD, Ilana Hellmann, MD, Tsila Zuckerman, MD, David Lavie, MD, Galia Stemer, MD, Raanan Cohen, MD, Ran Afik, PhD, Keren Ofek, PhD, Hilla Banayan, BSc MBA, Inna Kan, PhD, Moshe Grunspan, PhD, Yishai Ofran, MD, Yakir Moshe, MD PhD

Blood (2020) 136 (Supplement 1): 27–28.

https://doi.org/10.1182/blood-2020-139923

Published: 2020

Journal Articles

Durable Remissions and Increased Overall Survival in AML Patients Deemed Unfit for Standard Intensive Chemotherapy Achieved with High-Dose BST-236 (Aspacytarabine) Induction and Consolidation

Jessica K. Altman, MD, Selina M. Luger, MD FRCPC, Olga Frankfurt, MD, Tsila Zuckerman, MD, Jamie L. Koprivnikar, MD, Vamsi Kota, MD, Ashkan Emadi, MD, PhD, Bhavana Bhatnagar, DO, Dale L. Bixby, MD, Micah M. Burch, MD, Ofir Wolach, MD, Itai Levi, MD, Anna Gourevitch, MD, Ron Ram, MD, Liat Flaishon, PhD MD, Shoshi Tessler, PhD, Stela Gengrinovitch, PhD, Ruth Ben Yakar, PhD, Jacob M. Rowe, MB, BS

Blood (2020) 136 (Supplement 1): 9–10.

https://doi.org/10.1182/blood-2020-139136

Published: 2020

Journal Articles

Single-Agent Mosunetuzumab Is a Promising Safe and Efficacious Chemotherapy-Free Regimen for Elderly/Unfit Patients with Previously Untreated Diffuse Large B-Cell Lymphoma

Adam J Olszewski, MD, Abraham Avigdor, MD, Sunil Babu, Itai Levi, MD, Uri Abadi, Houston Holmes, Matthew McKinney, Ron McCord, Yuying Xie, Cindy Chen, Kati Sarouei, Naseer Qayum, Carol O'Hear, Gila Sellam, Herbert Eradat

Blood (2020) 136 (Supplement 1): 43–45.

https://doi.org/10.1182/blood-2020-136255

Published: 2020

Journal Articles

Aspacytarabine (BST-236) Is Safe and Efficacious As a Single-Agent, First-Line Therapy for Patients with Acute Myeloid Leukemia Unfit for Standard Chemotherapy. Integrated Results from a Phase 1/2a and an Ongoing Phase 2b

Jessica K. Altman, Tsila Zuckerman, MD, Olga Frankfurt, MD, Selina M. Luger, MD FRCPC, Dale L. Bixby, MD, Vamsi Kota, MBBS, Micah M. Burch, Ofir Wolach, Itai Levi, MD, Anna Gourevitch, Ron Ram, MD, Liat Flaishon, Shoshi Tessler, Stela Gengrinovitch, Ruth Ben Yakar, Jacob M. Rowe, MB, BS

Blood (2019) 134 (Supplement_1): 179.

https://doi.org/10.1182/blood-2019-124330

Published: 2019

Journal Articles

Radiation-Free Protocol for Patients with Acute Lymphoblastic Leukemia and Mixed Phenotype Acute Leukemia Undergoing Induction Chemotherapy and Allogeneic Hematopoietic Cell Transplantation - a Multicenter Historical Prospective Study

Odelia Amit, MD, Yael Bar-On, MD, Irit Avivi, Tsila Zuckerman, MD, Galit Perets, MD, Israel Henig, MD, Itai Levi, MD, Dana Yehudai-Ofir, MD, Shimrit Ringelstein Harlev, MD, Ron Ram, MD

Blood (2019) 134 (Supplement_1): 5654.

https://doi.org/10.1182/blood-2019-128248

Published: 2019

Journal Articles

Safety and Efficacy of Blinatumomab- Real World Data

Arie Apel, MD, Yishai Ofran, MD, Ron Ram, MD, Itai Levi, MD, Miri Zektser, MD, Maya Koren-Michowitz, MD

Blood (2018) 132 (Supplement 1): 5209.

https://doi.org/10.1182/blood-2018-99-116183

Published: 2018

Journal Articles

Variable Clinical Presentation of Congenital Thrombotic Thrombocytopenic Purpura in a Large Cohort of Patients Carrying a New Mutation in the CUB1 Domain of ADAMTS13 Gene

Oleg Pikovsky, Maram Arafat, MSc, Hilla Ovadia, PhD, Yoav Sharoni, PhD, Kayed Al-Athamen, MD, Bibi Kanengisser-Pines, MD, Anat Keren-Politansky, PhD, Itai Levi, MD, Ruti Parvari, PhD, Anat Rabinovich, MD

Blood (2018) 132 (Supplement 1): 1139.

https://doi.org/10.1182/blood-2018-99-111253

Published: 2018

Journal Articles

Results of a Phase II of Low-Dose Fludarabine and Cyclophosphamide Combined with Standard Dose Rituximab (FCR-LITE) in Elderly, Untreated Patients with Chronic Lymphocytic Leukemia (CLL): The Israeli CLL Study Group Experience

Tamar Tadmor, MD, Yair Herishanu, MD, Andrei Braester, MD, Osnat Bairey, MD, Ariel Aviv, Naomi Rahimi-Levene, MD, Riva Fineman, MD, Itai Levi, MD, Mona Yuklea, MD, Rosa Ruchlemer, MD, Lev Shvidel, MD, Aaron Polliack, MD

Blood (2018) 132 (Supplement 1): 5566.

https://doi.org/10.1182/blood-2018-99-111681

Published: 2018

Journal Articles

T he Effect of A dherence-Encouraging Interventions on Adherence to Tyrosine K inas e I nhibitor T reatment in Chronic Myeloid Leukemia ( TAKE-IT ): A Pre-Post Intervention Pilot Study

Avi Leader, MD, Noam Benyamini, MD, Sabina De Geest, PhDRN, Juliet Dreyer, RN MA, Bronya Calvarysky, MSc Clin Pharm, Sara Gechler, PhD, Alina Amitai, PharmD, Osnat Jarchowsky-Dolberg, MD, Giora Sharf, Eric Tousset, M.Sc., Opher Caspi, MDPhD, Martin Ellis, MD, Itai Levi, MD, Anat Gafter-Gvili, MD, Pia Raanani, MD

Blood (2015) 126 (23): 4034.

https://doi.org/10.1182/blood.V126.23.4034.4034

Published: 2015

Journal Articles

High Risk Advanced Stage Hodgkin Lymphoma Is Well Controlled with 2 Cycles of Escalated Beacopp Followed By 4 Cycles of ABVD in Patients Who Rapidly Achieve Metabolic CR on Interim PET/CT Scan

Meirav Kedmi, MD, Arie Apel, MD, Tima Davidson, MD, Elinor Goshen, MD, Yaron Davidovitz, MD, Miriam Berkowicz, MD, Itai Levi, MD, Eldad J. Dann, MD, Aaron Polliack, MD, Arnon Nagler, MD, Abraham Avigdor, MD

Blood (2014) 124 (21): 4442.

https://doi.org/10.1182/blood.V124.21.4442.4442

Published: 2014

Journal Articles

Efficacy and Safety of Autologus Hematopoietic Cell Transplantation in Elderly Patients with Multiple Myeloma: A Retrospective Israeli Multi-Site Cohort Study

Yael C Cohen, MD, Tsila Zuckerman, MD, Moshe Yeshurun, MD, Galit Perez, MD, Hila Magen, MD, Israel Henig, MD, Itai Levi, MD, Liat Shargian, Svetlana Trestman, MD, Uri Rouvio, MD, Elizabeth Naparstek, MD, Eti Ganon-Elazar, PhD, Irit Avivi, MD, Ron Ram, MD

Blood (2014) 124 (21): 3989.

https://doi.org/10.1182/blood.V124.21.3989.3989

Published: 2014

Journal Articles

Low Vs. High Intensity BEAM Prior To Autologous Hematopoietic Cell Transplantation For Chemosensitive Lymphoma Patients - A Matched Cohort Analysis

Galit Perez Avraham, MD, Moshe Yeshurun, MD, Itai Levi, MD, Corina Hershcovici, MD, Ory Rouvio, MD, PhD, Oleg Pikovsky, MD, Ofer Shpilberg, M.D, M.P.H, Ron Ram, MD

Blood (2013) 122 (21): 3391.

https://doi.org/10.1182/blood.V122.21.3391.3391

Published: 2013

Journal Articles

High Levels of Soluble Serum Hemojuvelin in Patients with Congenital Dyserythropoietic Anemia Type I,

Hannah Tamary, MD, Joseph Kapelushnik, M.D, Galit Perez-Avraham, MD, Itai Levi, MD, Carole Brasse-Lagnel, MD, Hanna Shalev, MD

Blood (2011) 118 (21): 3179.

https://doi.org/10.1182/blood.V118.21.3179.3179

Published: 2011

Journal Articles

A Multi-Center Prospective Randomized Study Comparing Ibritumomab Tiuxetan (Zevalin) and High-Dose BEAM Chemotherapy (Z-BEAM) Vs. BEAM Alone as the Conditioning Regimen Prior to Autologous Stem-Cell Transplantation In Patients with Aggressive Lymphoma; Possible Advantage for Z-BEAM In Low-Risk Patients

Avichai Shimoni, MD, Irit Avivi, MD, Jacob M. Rowe, Moshe Yeshurun, MD, Itai Levi, MD, Reuven Or, MD, Paulina Patachenko, MD, Abraham Avigdor, MD, Tzila Zwas, MD, Arnon Nagler, M.D.

Blood (2010) 116 (21): 686.

https://doi.org/10.1182/blood.V116.21.686.686

Published: 2010

Journal Articles

High Levels of Growth Differentiation Factor 15 in Patients with Congenital Dyserythtopoietic Anemia Type I

Hannah Tamary, MD, Hanna Shalev, MD, Galit Avraham, MD, Meira Zoldan, Itai Levi, MD, Dorine W. Swinkels, MD, PhD, Toshihiko Tanno, PhD, Jeffery L Miller, MD

Blood (2008) 112 (11): 3456.

https://doi.org/10.1182/blood.V112.11.3456.3456

Published: 2008

Journal Articles

Combined escBEACOPP-ABVD Therapy for Advanced Hodgkin’s Lymphoma Patients with High IPS Score: An Effective Regimen and Low Positive Predictive Value of Early FDG-PET/CT Scan.

Abraham Avigdor, MD, Shlomo Bulvik, MD, Eldad Dann, MD, Itai Levi, MD, Galit Perez-Avraham, MD, Noga Shemtov, MD, Avichai Shimoni, MD, Arnon Nagler, MD, Isaac Ben-Bassat, MD, Aaron Polliack, MD

Blood (2007) 110 (11): 2319.

https://doi.org/10.1182/blood.V110.11.2319.2319

Published: 2007

Journal Articles

Elevation of Normal B Cells in Children with ALL Can Predict Relapse.

Joseph Kapelushnik, MD, Itai Levi, MD, Tikva Yermoau, MD, Asher Moser, MD, Atamma Haj-Yhia, MS, Geora Shubinski, PHD

Blood (2004) 104 (11): 4445.

https://doi.org/10.1182/blood.V104.11.4445.4445

Published: 2004

Journal Articles

TPCK Induces Apoptosis in Human Acute Myeloid Leukemia U-937 Cells.

Julia Mazar, PhD, Alexandra Lichtenstein, MSc, Leora Katz, MSc, Ofer Shpilberg, MD, MPH, Itai Levi, MD, Ilana Nathan, PhD

Blood (2004) 104 (11): 4478.

https://doi.org/10.1182/blood.V104.11.4478.4478

Published: 2004

Journal Articles

Mimosine Induces Apoptosis through Metal Ion Chelation, Mitochondrial Activation and Reactive Oxygen Species Production in Human Leukemic Cells.

Maher Hallak, MSc, Alexander Dvilansky, MD, Ofer Shpilberg, MD, MPH, Itai Levi, MD, Julia Mazar, PhD, Ilana Nathan, PhD

Blood (2004) 104 (11): 4481.

https://doi.org/10.1182/blood.V104.11.4481.4481

Published: 2004

Journal Articles

A Pilot Study of Combined Escalated BEACOPP-ABVD Therapy for Advanced Hodgkin’s Lymphoma Patients with High IPS Score: The Israel Cooperative Lymphoma Group.

Abraham Avigdor, MD, Shlomo Bulvik, MD, Noga Shemtov, MD, Itai Levi, MD, Miriam Berkowicz, MD, Dina Ben-Yehuda, MD, Dorit Blickstein, MD, Neta Goldschmidt, MD, Alexander Gural, MD, Abraham Kornberg, MD, Dianna Libster, MD, Drorit Merkel, MD, Elizabeth Naparstek, MD, Pia Raanani, MD, Batia Roth, MD, Yulia Volchek, MD, Arnon Nagler, MD, Isaac Ben-Bassat, MD, Aaron Polliack, MD

Blood (2004) 104 (11): 4576.

https://doi.org/10.1182/blood.V104.11.4576.4576

Published: 2004

NARROW

First Results from a Nationwide Prospective Non-Interventional Study of Venetoclax-Based 1 st Line Therapies in Patients with Acute Myeloid Leukemia (AML) - Revive Study

Durable Remissions and Increased Overall Survival in AML Patients Deemed Unfit for Standard Intensive Chemotherapy Achieved with High-Dose BST-236 (Aspacytarabine) Induction and Consolidation

Single-Agent Mosunetuzumab Is a Promising Safe and Efficacious Chemotherapy-Free Regimen for Elderly/Unfit Patients with Previously Untreated Diffuse Large B-Cell Lymphoma

Aspacytarabine (BST-236) Is Safe and Efficacious As a Single-Agent, First-Line Therapy for Patients with Acute Myeloid Leukemia Unfit for Standard Chemotherapy. Integrated Results from a Phase 1/2a and an Ongoing Phase 2b

Radiation-Free Protocol for Patients with Acute Lymphoblastic Leukemia and Mixed Phenotype Acute Leukemia Undergoing Induction Chemotherapy and Allogeneic Hematopoietic Cell Transplantation - a Multicenter Historical Prospective Study

Safety and Efficacy of Blinatumomab- Real World Data

Variable Clinical Presentation of Congenital Thrombotic Thrombocytopenic Purpura in a Large Cohort of Patients Carrying a New Mutation in the CUB1 Domain of ADAMTS13 Gene

Results of a Phase II of Low-Dose Fludarabine and Cyclophosphamide Combined with Standard Dose Rituximab (FCR-LITE) in Elderly, Untreated Patients with Chronic Lymphocytic Leukemia (CLL): The Israeli CLL Study Group Experience

T he Effect of A dherence-Encouraging Interventions on Adherence to Tyrosine K inas e I nhibitor T reatment in Chronic Myeloid Leukemia ( TAKE-IT ): A Pre-Post Intervention Pilot Study

High Risk Advanced Stage Hodgkin Lymphoma Is Well Controlled with 2 Cycles of Escalated Beacopp Followed By 4 Cycles of ABVD in Patients Who Rapidly Achieve Metabolic CR on Interim PET/CT Scan

Efficacy and Safety of Autologus Hematopoietic Cell Transplantation in Elderly Patients with Multiple Myeloma: A Retrospective Israeli Multi-Site Cohort Study

Low Vs. High Intensity BEAM Prior To Autologous Hematopoietic Cell Transplantation For Chemosensitive Lymphoma Patients - A Matched Cohort Analysis

High Levels of Soluble Serum Hemojuvelin in Patients with Congenital Dyserythropoietic Anemia Type I,

High Levels of Growth Differentiation Factor 15 in Patients with Congenital Dyserythtopoietic Anemia Type I

Combined escBEACOPP-ABVD Therapy for Advanced Hodgkin’s Lymphoma Patients with High IPS Score: An Effective Regimen and Low Positive Predictive Value of Early FDG-PET/CT Scan.

Elevation of Normal B Cells in Children with ALL Can Predict Relapse.

TPCK Induces Apoptosis in Human Acute Myeloid Leukemia U-937 Cells.

Mimosine Induces Apoptosis through Metal Ion Chelation, Mitochondrial Activation and Reactive Oxygen Species Production in Human Leukemic Cells.

A Pilot Study of Combined Escalated BEACOPP-ABVD Therapy for Advanced Hodgkin’s Lymphoma Patients with High IPS Score: The Israel Cooperative Lymphoma Group.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only